TRCT
ONEM

Tower Research Capital (TRC)’s 1Life Healthcare ONEM Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,621
Closed -$127K – 6687
2022
Q4 		$127K Sell
7,621
-6,030
-44% -$102K 0.01% 1642
2022
Q3 		$234K Buy
13,651
+8,077
+145% +$127K ﹤0.01% 1771
2022
Q2 		$44K Buy
5,574
+3,170
+132% +$27.2K ﹤0.01% 3029
2022
Q1 		$27K Sell
2,404
-50
-2% -$560 ﹤0.01% 3270
2021
Q4 		$43K Sell
2,454
-3,967
-62% -$76.9K ﹤0.01% 2896
2021
Q3 		$130K Sell
6,421
-18,727
-74% -$481K ﹤0.01% 2179
2021
Q2 		$831K Buy
25,148
+17,555
+231% +$663K 0.02% 794
2021
Q1 		$297K Buy
7,593
+2,847
+60% +$134K 0.01% 1672
2020
Q4 		$207K Sell
4,746
-19,924
-81% -$681K 0.01% 1684
2020
Q3 		$700K Buy
24,670
+17,887
+264% +$565K 0.01% 1318
2020
Q2 		$246K Buy
+6,783
New +$191K 0.01% 1621

Tower Research Capital (TRC)'s ONEM Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 7,621 shares — an estimated $127K sold.

Tower Research Capital (TRC) first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $831K in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Tower Research Capital (TRC) reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,621 1Life Healthcare shares in Q1 2023, an estimated $127K.
  • Tower Research Capital (TRC) first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s 1Life Healthcare position peaked at $831K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.